Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_provenance.
- befree-2016 importedOn "2016-02-19" NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_provenance.
- NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_assertion wasGeneratedBy ECO_0000203 NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_provenance.
- NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_assertion wasDerivedFrom befree-2016 NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_provenance.
- NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_assertion SIO_000772 11907785 NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_provenance.
- NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_assertion evidence source_evidence_literature NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_provenance.
- NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_assertion description "[In peripheral blood of at least 50% of healthy individuals, the translocations t(9;22) BCR/ABL, t(14;18) IgH/BCL-2, t(2;5) NPM-ALK and MLL duplications, which characterize chronic myelogenous leukemia and acute lymphoblastic leukemia, follicular lymphoma, anaplastic large cell lymphoma, and acute myelogenous leukemia, respectively, are detectable by sensitive polymerase chain reaction (PCR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348877.RAZzK74Y-p3YTUaA0lKQjnDFInSyhh6UVypKJD3My2DHk130_provenance.